| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RenovoRx, Inc. | Director | Stock Options (right to buy) | 47,640 | 01 Oct 2025 | Direct | ||
| Quince Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 27,000 | 04 Jun 2025 | Direct | ||
| Quince Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 27,000 | 05 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNXT | RenovoRx, Inc. | 01 Oct 2025 | 1 | $0 | 4 | Director | 02 Oct 2025, 20:17 |
| QNCX | Quince Therapeutics, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:52 |
| RNXT | RenovoRx, Inc. | 01 Oct 2024 | 1 | $0 | 4 | Director | 02 Oct 2024, 16:30 |
| QNCX | Quince Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 21:03 |
| RNXT | RenovoRx, Inc. | 01 Oct 2023 | 1 | $0 | 4 | Director | 02 Oct 2023, 16:15 |
| QNCX | Quince Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 26 May 2023, 17:50 |
| RNXT | RenovoRx, Inc. | 01 Oct 2022 | 1 | $0 | 4 | Director | 04 Oct 2022, 16:44 |
| QNCX | Cortexyme, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 20:45 |
| RNXT | RenovoRx, Inc. | 10 Mar 2022 | 1 | $0 | 4 | Director | 14 Mar 2022, 16:53 |
| RNXT | RenovoRx, Inc. | 01 Oct 2021 | 1 | $0 | 4 | Director | 05 Oct 2021, 16:46 |
| RNXT | RenovoRx, Inc. | 25 Aug 2021 | 0 | $0 | 3 | Director | 25 Aug 2021, 17:24 |
| QNCX | Cortexyme, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 19:29 |